231 related articles for article (PubMed ID: 31839941)
21. Treatment of methicillin-sensitive Staphylococcus aureus bacteremia secondary to septic phlebitis using dalbavancin.
Cho JC; Estrada SJ; Beltran AJ; Revuelta MP
J Clin Pharm Ther; 2015 Oct; 40(5):604-606. PubMed ID: 26183753
[TBL] [Abstract][Full Text] [Related]
22. Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.
Lee B; Tam I; Weigel B; Breeze JL; Paulus JK; Nelson J; Allison GM
J Antimicrob Chemother; 2015 Aug; 70(8):2389-96. PubMed ID: 26024869
[TBL] [Abstract][Full Text] [Related]
23. Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study.
Campbell PO; Gallagher K; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
Int J Infect Dis; 2023 Sep; 134():172-176. PubMed ID: 37331565
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection.
Kilinc F; Setzer M; Behmanesh B; Jussen D; Gessler F; Bayerl S; Kempf VAJ; Kessel J; Czabanka M; Prinz V
Front Med (Lausanne); 2023; 10():1202969. PubMed ID: 37942421
[TBL] [Abstract][Full Text] [Related]
27. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.
Li J; Echevarria KL; Hughes DW; Cadena JA; Bowling JE; Lewis JS
Antimicrob Agents Chemother; 2014 Sep; 58(9):5117-24. PubMed ID: 24936596
[TBL] [Abstract][Full Text] [Related]
28. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
[TBL] [Abstract][Full Text] [Related]
29. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
Li J; Echevarria KL; Traugott KA
Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
[TBL] [Abstract][Full Text] [Related]
30. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia.
Rindone JP; Mellen CK
Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576
[TBL] [Abstract][Full Text] [Related]
31. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center.
Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF
Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053
[TBL] [Abstract][Full Text] [Related]
32. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of Cefazolin Versus Ceftriaxone for the Treatment of Methicillin-Susceptible
Carr DR; Stiefel U; Bonomo RA; Burant CJ; Sims SV
Open Forum Infect Dis; 2018 May; 5(5):ofy089. PubMed ID: 30568987
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
[TBL] [Abstract][Full Text] [Related]
35. Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.
Yan M; Elligsen M; Simor AE; Daneman N
Can J Infect Dis Med Microbiol; 2016; 2016():8435257. PubMed ID: 27366183
[TBL] [Abstract][Full Text] [Related]
36. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Loubet P; Burdet C; Vindrios W; Grall N; Wolff M; Yazdanpanah Y; Andremont A; Duval X; Lescure FX
Clin Microbiol Infect; 2018 Feb; 24(2):125-132. PubMed ID: 28698037
[TBL] [Abstract][Full Text] [Related]
37. Outpatient parenteral antimicrobial therapy (OPAT) in Christchurch: 18 years on.
Chambers ST; Basevi A; Gallagher K; Carswell-Moyna A; Isenman H; Pithie A; Dalton S; Metcalf SC
N Z Med J; 2019 Aug; 132(1501):21-32. PubMed ID: 31465324
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis.
Wen W; Li H; Wang C; Chen C; Tang J; Zhou M; Hong X; Cheng Y; Wu Q; Zhang X; Feng Z; Wang M
Rev Esp Quimioter; 2022 Aug; 35(4):370-377. PubMed ID: 35652306
[TBL] [Abstract][Full Text] [Related]
39. Impact of Cefazolin Shortage on Clinical Outcomes of Adult Patients with Bacteremia Caused by Methicillin-Susceptible
Uda A; Onuma K; Shigemura K; Kitagawa K; Yan Y; Osawa K; Yano I; Miyara T
Antibiotics (Basel); 2021 Oct; 10(10):. PubMed ID: 34680827
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
